Clinical Trial Update: The Study on the Pharmacokinetics of PEG-rhG-CSF in Children and Adolescents [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetic study of PEG-rhG-CSF in children and adolescents with acute lymphoblastic leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• PEG-rhG-CSF (pegylated recombinant human granulocyte colony-stimulating factor)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Acute Lymphoid Leukemia | Phase 4 | Status: COMPLETED